Blog
Get Started
Login
Sign Up - Free
Log In
Blog Home
Blog Categories
Benchsci Updates
Benchsci Case Studies
AI in Drug Discovery
AI in Drug Discovery Podcast
About BenchSci
BenchSci Updates
BenchSci Case Studies
AI in Drug Discovery
The BenchSci Blog
sort
Artificial Intelligence in Drug Discovery
Jun 11, 2018
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
BenchSci Analysis
Jun 7, 2018
Mammalian Model Organisms: Contributions and Limitations
BenchSci Case Studies
Jun 1, 2018
Dr. David Rimm on Antibodies, Reproducibility, and His Experience with BenchSci
Research Tips
May 30, 2018
The Current State of Alzheimer’s Disease Biomarkers
Artificial Intelligence in Drug Discovery
May 29, 2018
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
BenchSci Updates
May 21, 2018
Data Update: More Antibodies and Figures, Closed-Access Content, and New Filters
Career Development
May 17, 2018
7 Tips to Apply for a Non-Academic Job with a Life Science PhD
Therapeutic Antibodies
May 16, 2018
Recent Advances in Treatment of Stage IV Metastatic Breast Cancer: Anti-HER2 mAbs, TKIs, and ADCs
Artificial Intelligence in Drug Discovery
May 16, 2018
Mauro Cozzi, Co-founder of Researchably, on AI for Better Biomedical Search
Artificial Intelligence in Drug Discovery
May 14, 2018
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Research Tips
May 2, 2018
A Novel Method to Evaluate Clinical Efficacy of Pre-Infusion CD19 CAR-T Products
BenchSci Analysis
Apr 25, 2018
Introducing Predicted Cross-reactivity for Your Antibody Search
Never miss a blog post
Previous
Next
